Selected research
Industry Research
OTC Drug and Dietary Supplement Industry Research Report 2026
Market perspective
The global OTC Drug and Dietary Supplement market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the OTC Drug and Dietary Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the OTC Drug and Dietary Supplement market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the OTC Drug and Dietary Supplement market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of OTC Drug and Dietary Supplement include Abbott, Pfizer, GSK, Bayer, Suntory, Reckitt Benckiser, Herbalife, Glanbia and Blackmores and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global OTC Drug and Dietary Supplement market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to OTC Drug and Dietary Supplement.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OTC Drug and Dietary Supplement Market by Company
Abbott
Pfizer
GSK
Bayer
Suntory
Reckitt Benckiser
Herbalife
Glanbia
Blackmores
Amway
OTC Drug and Dietary Supplement Segment by Type
Powders
Capsules
Tablets
Liquids
OTC Drug and Dietary Supplement Segment by Application
Convenience Stores
Supermarkets
Pharmacies
OTC Drug and Dietary Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Drug and Dietary Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Drug and Dietary Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Drug and Dietary Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of OTC Drug and Dietary Supplement companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powders
- Capsules
- Tablets
- Liquids
Applications
- Convenience Stores
- Supermarkets
- Pharmacies
Companies covered
- Abbott
- Pfizer
- GSK
- Bayer
- Suntory
- Reckitt Benckiser
- Herbalife
- Glanbia
- Blackmores
- Amway
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 OTC Drug and Dietary Supplement by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Powders
- 2.2.3 Capsules
- 2.2.4 Tablets
- 2.2.5 Liquids
- 2.3 OTC Drug and Dietary Supplement by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Convenience Stores
- 2.3.3 Supermarkets
- 2.3.4 Pharmacies
- 2.4 Assumptions and Limitations
3 OTC Drug and Dietary Supplement Breakdown Data by Type
- 3.1 Global OTC Drug and Dietary Supplement Historic Market Size by Type (2021-2026)
- 3.2 Global OTC Drug and Dietary Supplement Forecasted Market Size by Type (2027-2032)
4 OTC Drug and Dietary Supplement Breakdown Data by Application
- 4.1 Global OTC Drug and Dietary Supplement Historic Market Size by Application (2021-2026)
- 4.2 Global OTC Drug and Dietary Supplement Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global OTC Drug and Dietary Supplement Market Perspective (2021-2032)
- 5.2 Global OTC Drug and Dietary Supplement Growth Trends by Region
- 5.2.1 Global OTC Drug and Dietary Supplement Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 OTC Drug and Dietary Supplement Historic Market Size by Region (2021-2026)
- 5.2.3 OTC Drug and Dietary Supplement Forecasted Market Size by Region (2027-2032)
- 5.3 OTC Drug and Dietary Supplement Market Dynamics
- 5.3.1 OTC Drug and Dietary Supplement Industry Trends
- 5.3.2 OTC Drug and Dietary Supplement Market Drivers
- 5.3.3 OTC Drug and Dietary Supplement Market Challenges
- 5.3.4 OTC Drug and Dietary Supplement Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top OTC Drug and Dietary Supplement Players by Revenue
- 6.1.1 Global Top OTC Drug and Dietary Supplement Players by Revenue (2021-2026)
- 6.1.2 Global OTC Drug and Dietary Supplement Revenue Market Share by Players (2021-2026)
- 6.2 Global OTC Drug and Dietary Supplement Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of OTC Drug and Dietary Supplement Head Office and Area Served
- 6.4 Global OTC Drug and Dietary Supplement Players, Product Type & Application
- 6.5 Global OTC Drug and Dietary Supplement Manufacturers Established Date
- 6.6 Global OTC Drug and Dietary Supplement Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America OTC Drug and Dietary Supplement Market Size (2021-2032)
- 7.2 North America OTC Drug and Dietary Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
- 7.4 North America OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe OTC Drug and Dietary Supplement Market Size (2021-2032)
- 8.2 Europe OTC Drug and Dietary Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
- 8.4 Europe OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific OTC Drug and Dietary Supplement Market Size (2021-2032)
- 9.2 Asia-Pacific OTC Drug and Dietary Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
- 9.4 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America OTC Drug and Dietary Supplement Market Size (2021-2032)
- 10.2 South America OTC Drug and Dietary Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
- 10.4 South America OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa OTC Drug and Dietary Supplement Market Size (2021-2032)
- 11.2 Middle East & Africa OTC Drug and Dietary Supplement Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
- 11.4 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.1.4 Abbott OTC Drug and Dietary Supplement Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Pfizer
- 12.2.1 Pfizer Company Information
- 12.2.2 Pfizer Business Overview
- 12.2.3 Pfizer Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.2.4 Pfizer OTC Drug and Dietary Supplement Product Portfolio
- 12.2.5 Pfizer Recent Developments
- 12.3 GSK
- 12.3.1 GSK Company Information
- 12.3.2 GSK Business Overview
- 12.3.3 GSK Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.3.4 GSK OTC Drug and Dietary Supplement Product Portfolio
- 12.3.5 GSK Recent Developments
- 12.4 Bayer
- 12.4.1 Bayer Company Information
- 12.4.2 Bayer Business Overview
- 12.4.3 Bayer Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.4.4 Bayer OTC Drug and Dietary Supplement Product Portfolio
- 12.4.5 Bayer Recent Developments
- 12.5 Suntory
- 12.5.1 Suntory Company Information
- 12.5.2 Suntory Business Overview
- 12.5.3 Suntory Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.5.4 Suntory OTC Drug and Dietary Supplement Product Portfolio
- 12.5.5 Suntory Recent Developments
- 12.6 Reckitt Benckiser
- 12.6.1 Reckitt Benckiser Company Information
- 12.6.2 Reckitt Benckiser Business Overview
- 12.6.3 Reckitt Benckiser Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.6.4 Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
- 12.6.5 Reckitt Benckiser Recent Developments
- 12.7 Herbalife
- 12.7.1 Herbalife Company Information
- 12.7.2 Herbalife Business Overview
- 12.7.3 Herbalife Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.7.4 Herbalife OTC Drug and Dietary Supplement Product Portfolio
- 12.7.5 Herbalife Recent Developments
- 12.8 Glanbia
- 12.8.1 Glanbia Company Information
- 12.8.2 Glanbia Business Overview
- 12.8.3 Glanbia Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.8.4 Glanbia OTC Drug and Dietary Supplement Product Portfolio
- 12.8.5 Glanbia Recent Developments
- 12.9 Blackmores
- 12.9.1 Blackmores Company Information
- 12.9.2 Blackmores Business Overview
- 12.9.3 Blackmores Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.9.4 Blackmores OTC Drug and Dietary Supplement Product Portfolio
- 12.9.5 Blackmores Recent Developments
- 12.10 Amway
- 12.10.1 Amway Company Information
- 12.10.2 Amway Business Overview
- 12.10.3 Amway Revenue in OTC Drug and Dietary Supplement Business (2021-2026)
- 12.10.4 Amway OTC Drug and Dietary Supplement Product Portfolio
- 12.10.5 Amway Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst